Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression (Q45277258)

11 December 2017

Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression (English)

1 reference

11 December 2017

1 reference

6

Altshuler LL

1 reference

11 December 2017

2

London ED

1 reference

11 December 2017

Bauer M

1

1 reference

11 December 2017

Rasgon N

3

1 reference

11 December 2017

Berman SM

4

1 reference

11 December 2017

Frye MA

5

1 reference

11 December 2017

Mandelkern MA

7

1 reference

11 December 2017

Bramen J

8

1 reference

11 December 2017

Voytek B

9

1 reference

11 December 2017

Woods R

10

1 reference

11 December 2017

Mazziotta JC

11

1 reference

11 December 2017

Whybrow PC

12

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

11 December 2017

1 reference

11 December 2017

10

1 reference

11 December 2017

5

1 reference

11 December 2017

456-469

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001647

11 December 2017

0 references

cites work

Beyond lithium in the treatment of bipolar illness.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: an open clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Treatment of refractory depression with high-dose thyroxine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Treatment of refractory chronic depression and dysthymia with high-dose thyroxine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Cerebral blood flow and oxygen consumption in hyperthyroidism before and after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

The cerebral circulation and metabolism in hyperthyroidism and myxedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Cerebral-cortex perfusion-rates in myxoedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Thyroid hormones and the treatment of depression: an examination of basic hormonal actions in the mature mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Thyroid hormone-induced plasticity in the adult rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Functional neuroimaging studies of depression: the anatomy of melancholia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Neuroimaging studies of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Prefrontal-subcortical and limbic circuit mediation of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Neuroimaging in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Subgenual prefrontal cortex abnormalities in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Reduction of prefrontal cortex glucose metabolism common to three types of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

fMRI during affect discrimination in bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Statistical parametric maps in functional imaging: A general linear approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Thyroid hormone, neural tissue and mood modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Nuclear Triiodothyronine Receptor Sites in Brain: Probable Identity with Hepatic Receptors and Regional Distribution*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Regional distribution of nuclear T3 receptors in rat brain and evidence for preferential localization in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Reduced left hemispheric white matter volume in twins with bipolar I disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

MRI investigation of temporal lobe structures in bipolar patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Cerebral glucose utilization is reduced in second test session.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

The assessment and analysis of handedness: The Edinburgh inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Spatial registration and normalization of images

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Clinical observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

7 January 2021

Thyroid hormones and brain development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

7 January 2021

Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

7 January 2021

MRI-PET registration with automated algorithm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

7 January 2021

Bone mineral density and L-thyroxine treatment in rapidly cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

7 January 2021

MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001647

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001647

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference